Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FLXN

Flexion Therapeutics (FLXN) Stock Price, News & Analysis

Flexion Therapeutics logo

About Flexion Therapeutics Stock (NASDAQ:FLXN)

Advanced Chart

Key Stats

Today's Range
$25.08
$25.08
50-Day Range
$9.12
$9.44
52-Week Range
$4.30
$13.66
Volume
2 shs
Average Volume
1.18 million shs
Market Capitalization
$1.26 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FLXN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Flexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FLXN Stock News Headlines

July 4th: 59% dividend from Bitcoin (No Crypto Needed)
I've got something exciting for you this July 4th holiday... How about a 59.07% dividend from Bitcoin? Yes, you read that right. And no, you don't need to buy any cryptocurrency or trade options... Here's the deal: Our July 4th special includes a FREE report on what I call the "Bitcoin Income Vault."
VIRI Virios Therapeutics, Inc.
Spyre Therapeutics Inc SYRE
PFIZER INC's Net Worth
See More Headlines

FLXN Stock Analysis - Frequently Asked Questions

Flexion Therapeutics, Inc. (NASDAQ:FLXN) posted its quarterly earnings results on Wednesday, May, 12th. The specialty pharmaceutical company reported ($0.57) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.49) by $0.08. The specialty pharmaceutical company earned $24.59 million during the quarter, compared to analyst estimates of $24.61 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Flexion Therapeutics investors own include Regulus Therapeutics (RGLS), NVIDIA (NVDA), Gilead Sciences (GILD), Bristol Myers Squibb (BMY), Lipocine (LPCN), Micron Technology (MU) and Viking Therapeutics (VKTX).

Company Calendar

Last Earnings
5/12/2021
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FLXN
Employees
257
Year Founded
2007

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$113.71 million
Net Margins
-100.32%
Pretax Margin
-100.32%

Debt

Sales & Book Value

Annual Sales
$85.55 million
Price / Cash Flow
N/A
Book Value
($0.34) per share
Price / Book
-73.76

Miscellaneous

Free Float
45,727,000
Market Cap
$1.26 billion
Optionable
No Data
Beta
1.53

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:FLXN) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners